Seduksen en es it fr

Seduksen Brand names, Seduksen Analogs

Seduksen Brand Names Mixture

  • No information avaliable

Seduksen Chemical_Formula


Seduksen RX_link

Seduksen fda sheet

Seduksen msds (material safety sheet)

Seduksen MSDS

Seduksen Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Seduksen Molecular Weight

284.74 g/mol

Seduksen Melting Point


Seduksen H2O Solubility

Slightly soluble (50 mg/L)

Seduksen State


Seduksen LogP


Seduksen Dosage Forms

Tablets; Injectable solution

Seduksen Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Seduksen Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Seduksen Absorption

Essentially complete, with a bioavailability of 93%.

Seduksen side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Seduksen Patient Information

Seduksen Organisms Affected

Humans and other mammals